Kurt R. Oettel
-
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 3
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 4
- Prostate Cancer Treatment and Research 3
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- R ErbesPaul FischM. RaffenbergH. LodeH. MauchPaul M. SondelMiroslav MalkovskýJean E. Surfus
- Journals
- Journal of Clinical Oncology (7 papers)The Journal of Immunology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Kurt R. Oettel
25 papers receiving 527 citations
Peers
Comparison fields: 5 of 77
- Oncology 200
- Critical Care and Intensive Care Medicine 26
- Immunology 95
- Pulmonary and Respiratory Medicine 133
- Infectious Diseases 71
Countries citing papers authored by Kurt R. Oettel
This map shows the geographic impact of Kurt R. Oettel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt R. Oettel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt R. Oettel more than expected).
Fields of papers citing papers by Kurt R. Oettel
This network shows the impact of papers produced by Kurt R. Oettel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt R. Oettel. The network helps show where Kurt R. Oettel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kurt R. Oettel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 8 | |
| 5 | 2018 | 18 | |
| 6 | 2017 | 33 | |
| 7 | 2017 | 60 | |
| 8 | 2016 | 5 | |
| 9 | 2013 | 57 | |
| 10 | 2013 | 34 | |
| 11 | 2012 | 9 | |
| 12 | 2010 | 1 | |
| 13 | 2008 | 2 | |
| 14 | 2007 | 9 | |
| 15 | 2006 | 6 | |
| 16 | 2006 | 88 | |
| 17 | 2005 | 9 | |
| 18 | 2003 | 45 | |
| 19 | Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer. | 2002 | 57 |
| 20 | 1989 | 21 |
About Kurt R. Oettel
Kurt R. Oettel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 25 papers that have together received 545 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Genomics and Diagnostics (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Oncology (200 citations), Critical Care and Intensive Care Medicine (26 citations) and Immunology (95 citations). Kurt R. Oettel has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include R Erbes, Paul Fisch, M. Raffenberg, H. Lode, H. Mauch, Paul M. Sondel, Miroslav Malkovský, Jean E. Surfus, George Wilding and Mary Jane Staab. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.